Pfizer PFE is facing one of the steepest patent cliffs in the large-cap pharma space. The company expects a significant ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is also the author of the morning Pharmalittle newsletter ...

Those eager to discredit Pfizer's mRNA vaccine, which is safe and effective, exploited the cruise ship outbreak.

The race to greenlight a COVID-19 vaccine in the United States has entered its final sprint, with one leading candidate becoming the first to release preliminary results showing its vaccine is more ...

Pfizer said on ​Tuesday that it expects to return to stronger growth after 2028, driven by obesity drugs in development, a ...

The Biden administration withheld data from the public on the risks of myocarditis from the Covid vaccine, Food and Drug Administration Commissioner Marty Makary claimed Thursday — a bold accusation ...

A rare hantavirus outbreak on an Atlantic cruise ship has reignited conspiratorial Covid-era misinformation, with posts ...

According to the Centers for Disease Control and Prevention's COVID ⁠dashboard, new data is currently unavailable due to low ...

(The Hill) – The Food and Drug Administration (FDA) is considering revoking the authorization of Pfizer’s COVID-19 vaccine for healthy children younger than 5 years old, a move that would add another ...

Pfizer reported lower third-quarter profit and sales as demand for its Covid-19 vaccine and antiviral drug continue to decline. The drug maker posted net income of $3.54 billion, or 62 cents a share, ...

The CDC Wednesday said younger males should consider waiting longer between doses of the Pfizer-BioNTech and Moderna COVID-19 vaccines in order to reduce the risk of a rare form of heart inflammation.